Inventor · London, GB

Angus Dalgleish

23Patents
6h-index
27Co-inventors
69Inventor score

Filing activity: Oct 14, 1994 → Jun 18, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US8715677B2 Immunological uses of immunomodulatory compounds for vaccine and anti-infectious disease therapy Emerging Cross-Sectional Technologies 48 Active
US10758514B2 Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity in the treatment of a brain tumour Human Necessities 19 Active
US6699483B1 Cancer treatments Human Necessities 13 Expired
US11000486B2 Combination of cannabinoids in the treatment of leukaemia Human Necessities 12 Active
US5935579A AIDS therapy and vaccine Mechanical Engineering; Lighting; Heating 8 Expired
US6972128B1 Use of human prostrate cell lines in prostate cancer treatment Human Necessities 6 Expired
US8841325B2 Immunomodulatory compounds for the restoration of vitamin D sensitivity in vitamin D resistant tumor cells Physics 2 Active
US9895438B2 Treatment of cancer with naltrexone Human Necessities 2 Active
US12161607B2 Combination of cannabinoids in the treatment of leukemia Human Necessities 1 Active
US8097244B2 Human prostate cell lines in cancer treatment Human Necessities 1 Active
US7438922B2 Human prostate cell lines in cancer treatment Human Necessities 1 Expired
US11351165B2 Agent that increases the expression of the opioid kappa 1 for the treatment of cancer Physics 0 Active
US11885796B2 Assay to identify anti-cancer agents Physics 0 Active
US12029737B2 Autoimmune therapy Human Necessities 0 Active
US11607423B2 Combination of a cannabinoid and a chemotheraopeutic agent for the treatment of breast cancer Human Necessities 0 Active
US11065245B2 Priming of cancer cells with low dose naltrexone Physics 0 Active
US9200065B2 Peptide constructs derived from the GP120 C5 domain and GP41 transmembrane domain Chemistry; Metallurgy 0 Active
US9226913B2 Methods of treating cancer using a combination of an immunomodulatory compound and an artemisinin or a derivative thereof Human Necessities 0 Active
US10251949B2 Stabilized HIV-1 peptide constructs comprising the gp120 C5 domain and gp41 hydrophilic domain Chemistry; Metallurgy 0 Active
US12144807B2 Priming of cancer cells with low dose naltrexone Physics 0 Active
US8545835B2 Human prostate cell lines in cancer treatment Human Necessities 0 Active
US8034360B2 Use of human prostate cell lines in cancer treatment Human Necessities 0 Expired
US11304943B2 Combination for use in the treatment of lung cancer Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.